Misty Jenkins

Q: What Schools Are Affiliated With Misty Jenkins

Misty Jenkins is affiliated with the following schools: La Trobe University, University of Melbourne, University of Cambridge

Misty Jenkins's AcademicInfluence.com Rankings

Misty Jenkins

Philosophy

#12757

World Rank

#17802

Historical Rank

Logic

#9698

World Rank

#12334

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Misty Jenkins's Degrees

PhD Immunology University of Melbourne

Why Is Misty Jenkins Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Misty Rayna Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment. Jenkins leads an Immunology Laboratory at the Walter and Eliza Hall Institute of Medical Research where she researches brain cancer and aims to establish a world-leading immunotherapy lab specialising in researching the possibilities of new treatments for both adult and paediatric brain cancer.

(See a Problem?)

Misty Jenkins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. (2004) (329)
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. (2013) (193)
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity (2018) (182)
Addition of a Prominent Epitope Affects Influenza A Virus-Specific CD8+ T Cell Immunodominance Hierarchies When Antigen Is Limiting1 (2006) (175)
Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time (2015) (170)
The Strength of T Cell Receptor Signal Controls the Polarization of Cytotoxic Machinery to the Immunological Synapse (2009) (154)
Cytotoxic T lymphocyte–induced killing in the absence of granzymes A and B is unique and distinct from both apoptosis and perforin-dependent lysis (2006) (97)
Centrosome docking at the immunological synapse is controlled by Lck signaling (2011) (94)
The synapse and cytolytic machinery of cytotoxic T cells. (2010) (92)
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells (2015) (86)
Heterogeneity of Effector Phenotype for Acute Phase and Memory Influenza A Virus-Specific CTL1 (2007) (86)
A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel (2007) (76)
Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse (2013) (76)
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma (2018) (67)
Towards Immunotherapy for Pediatric Brain Tumors. (2019) (60)
Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory (2007) (59)
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice (2017) (51)
Cell Cycle-Related Acquisition of Cytotoxic Mediators Defines the Progressive Differentiation to Effector Status for Virus-Specific CD8+ T Cells1 (2008) (42)
Granzyme K expressing cytotoxic T lymphocytes protects against influenza virus in granzyme AB-/- mice. (2008) (40)
Distinct structural and catalytic roles for Zap70 in formation of the immunological synapse in CTL (2014) (37)
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models. (2017) (36)
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies (2020) (36)
Human γδ T‐cell receptor repertoire is shaped by influenza viruses, age and tissue compartmentalisation (2019) (34)
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion (2020) (29)
Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity (2016) (27)
Cell Cycle-Related Acquisition of Cytotoxic Mediators Defines the Progressive Differentiation to Effector Status for Virus-Specific CD8 T Cells (2008) (25)
Visualizing CTL activity for different CD8+ effector T cells supports the idea that lower TCR/epitope avidity may be advantageous for target cell killing (2009) (23)
The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells (2019) (22)
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ Tumors. (2017) (17)
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (2021) (12)
CAR-T cells are serial killers (2015) (12)
Equitable Expanded Carrier Screening Needs Indigenous Clinical and Population Genomic Data. (2020) (12)
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy (2021) (10)
Infections in the Intensive Care Unit (2017) (9)
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells (2022) (7)
Perforin-dependent cytotoxicity: ‘Kiss of death’ or prolonged embrace with darker elocation-idnseque11es? (2015) (7)
De novo-designed transmembrane domains tune engineered receptor functions (2022) (7)
Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (2021) (7)
Programming a serial killer: CAR T cells form non-classical immune synapses (2018) (6)
To go or not to go? Biological logic gating engineered T cells (2022) (4)
DNA Nation raises tough questions for Indigenous Australians (2016) (4)
A community-based co-designed genetic health service model for Aboriginal Australians (2020) (3)
De novo designed receptor transmembrane domains enhance CAR-T cell cytotoxicity and attenuate cytokine release (2020) (3)
“This is my boy’s health! Talk straight to me!” perspectives on accessible and culturally safe care among Aboriginal and Torres Strait Islander patients of clinical genetics services (2020) (2)
Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers (2016) (2)
receptors is a susceptibility locus for Generalised Epilepsies (2004) (2)
Targeting Mechanisms for Natural Killer Cell Dysfunction in Patients with Multiple Myeloma (2015) (2)
Challenges and opportunities in 2021 (2021) (1)
facilitate rapid access of granzymes during killer cell attack Perforin forms transient pores on the target cell plasma membrane to (2013) (1)
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma (2018) (1)
CAR-T Cells Are Serial Killers of Tumor Cells (2015) (1)
Investigating disparity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people (2022) (1)
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma (2023) (0)
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy. (2023) (0)
PF568 INVESTIGATING MECHANISMS OF ELOTUZUMAB AND LENALIDOMIDE THERAPY IN MULTIPLE MYELOMA (2019) (0)
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma (2023) (0)
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells (2022) (0)
Sepsis Update: A New Core Measure of Quality. (2016) (0)
A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse (2021) (0)
Abstract B10: Individual CAR-T cells, when activated via their CAR or TCR, kill tumor cells with similar kinetics and can kill multiple sequential tumor targets (2015) (0)
Delivery at the Cytotoxic Immune Synapse Rapid and Unidirectional Perforin Pore (2013) (0)
Combination elotuzumab and lenalidomide treatment efficacy is dependent on crosstalk between NK cells, monocytes and myeloma cells. (2022) (0)
Virus-Specific CTL Acute Phase and Memory Influenza A Heterogeneity of Effector Phenotype for and (2007) (0)
Virus-Specific CD 8 Differentiation to Effector Status for Mediators Defines the Progressive Cell Cycle-Related Acquisition of Cytotoxic (2008) (0)
A comprehensive analysis of granzyme/perforin expression and cytotoxic function of influenza-specific CD8(+) T cells (2005) (0)
Investigating equity in access to Australian clinical genetic health services for Aboriginal and Torres Strait Islander people (2021) (0)
Antigen Is Limiting Immunodominance Hierarchies When T Cell + Influenza A Virus-Specific CD8 Addition of a Prominent Epitope Affects (2006) (0)

This paper list is powered by the following services:

Other Resources About Misty Jenkins

What Schools Are Affiliated With Misty Jenkins?

Misty Jenkins is affiliated with the following schools:

Misty Jenkins's Academic­Influence.com Rankings